The global MRI-safe neurostimulation systems market is entering a period of extraordinary growth, with 2023 shaping up to be a pivotal year. Recent market data indicates that the market size is estimated to have reached US$ 278.5 million in 2023, showing significant growth compared to the preceding year’s figures. Moreover, the market is poised to flourish, with a remarkable Compound Annual Growth Rate (CAGR) of 15.3% projected between 2023 and 2033, culminating in a substantial market valuation of around US$ 1,158.9 million by 2033.
Neurological disorders have become a global health concern, and as awareness of neurodegenerative conditions continues to rise, the demand for MRI-Safe neurostimulation systems has gained substantial momentum. These innovative systems offer a novel approach to diagnosing and treating neurological conditions while ensuring patient safety during MRI procedures, a key factor driving the market’s rapid expansion.
Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-4978
Key Drivers of Market Growth:
1. Rising Prevalence of Neurological Disorders: The increasing incidence of neurological disorders, including neurodegenerative conditions like Alzheimer’s and Parkinson’s disease, has heightened the demand for advanced diagnostic and treatment solutions.
2. MRI Compatibility: MRI-Safe neurostimulation systems provide a unique advantage, as they enable healthcare professionals to conduct magnetic resonance imaging while simultaneously delivering neurostimulation therapy, enhancing the quality of patient care.
3. Advancements in Medical Technology: Ongoing advancements in medical technology have led to the development of more efficient and user-friendly neurostimulation systems, attracting both healthcare providers and patients.
4. Healthcare Awareness: Greater awareness of the potential benefits of neurostimulation therapy for various neurological conditions has driven its adoption.
Key Companies:
- Medtronic Inc.
- Cyberonics, Inc.
- AADCO Medical Inc.
- Boston Scientific
- Sorin
- St. Jude Medical
- Biotronik
- Codman & Shurtleff’s
- Nevro Corporation
- Boston Scientific Corporation
Key Segments:
By Product:
- Implantable
- Transcutaneous
By Application:
- Spinal Cord Stimulation (SCS)
- Peripheral Nerve Stimulation
- Intracranial Stimulation
- Deep Brain Stimulation
- Motor Cortex Stimulation
- Sensory Nerve Stimulation
- Vagus Nerve Stimulation
By End User:
- Hospitals & Clinics
- Diagnostic Labs and Centers
- Ambulatory Surgical Centers
- Research Laboratories
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia & Pacific
- East Asia
- Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
